Jing Zhu

OX40R (TNFRSF4) bound to Fab 1A7

Wadim L. Matochko, G. A. Lazar, M. Ultsch, 2019 .

Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members

Wadim L. Matochko, G. A. Lazar, M. Ultsch, 2019, mAbs.

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors

T. Ho, C. Blank, M. Sznol, 2021, Current oncology.

T cell co-stimulatory receptor CD28 is a primary target for PD-1–mediated inhibition

R. Vale, Marcus J. Taylor, I. Mellman, 2016, bioRxiv.

T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition

Ronald D. Vale, Ira Mellman, Jun Huang, 2016, Science.

Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Results From a Phase 1b Trial.

M. Gordon, D. Wong, T. Bauer, 2021, Clinical lung cancer.